Fujian Province β‐Thalassemia: A Molecular and Hematological Study in Southeastern China
Genetics Research · 2025-01 · 2025 (1)
DOI: 10.1155/genr/8862095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics Research, online erschienen am 08.06.2025. Verfasst von Junhao Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: The School of Medical Technology and Engineering, Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: beta-Thalassemia, beta-Globins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province, National Key Clinical Specialty Discipline Construction Program of China.
Abstract (Originalsprache)
Background
This study aims to investigate the mutation spectrum of β‐thalassemia in Fujian Province, China, and to comprehensively analyze the correlation between age, gender, genotype, and hematological parameters in carriers of β‐thalassemia.
Methods
Genotypes of 10,350 subjects suspected of having thalassemia were analyzed using reverse dot blotting (RDB) or β‐globin gene sequencing. Their hematological indices were analyzed by genotype, gender, and age.
Results
Among the subjects, 1214 (11.73%) were identified as β‐thalassemia carriers. The prevalent genotypes included IVS‐II‐654 (C > T)/N (37.56%), CD 41‐42 (‐TTCT)/N (30.72%), CD 17 (A > T)/N (9.64%), −28 (A > G)/N (7.00%), CD 27‐28 (+C)/N (3.21%), and CD 26 (GAG > AAG)/N (3.05%). Two rare mutations, Cap+22 (G > A) and IVS‐II‐806 (G > C), were detected, with the latter being part of a double heterozygous condition with hemoglobin (Hb) New York, compound −α4.2/αα, and Hb Q Thailand, marking the first report in Chinese individuals. Hematological analysis revealed that the CD 26 group exhibited higher levels of Hb, mean corpuscular volume (MCV), and mean corpuscular hemoglobin (MCH) compared to the β 0 and β + groups ( p < 0.05). Within the β + group, individuals with −28 (A > G)/N showed significantly higher Hb, MCV, and MCH levels compared to those with IVS‐II‐654 (C > T)/N. Adult males had higher Hb levels than adult females, and adult patients generally had higher MCV and MCH levels than minors ( p < 0.05).
Conclusion
This study represents the first comprehensive molecular epidemiological investigation and hematological analysis of β‐thalassemia in Fujian Province, providing support for the optimization of prevention and control strategies for thalassemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The School of Medical Technology and Engineering, Fujian Medical University, Fuzhou, China.
- Key Laboratory of Clinical Laboratory Technology for Precision Medicine (Fujian Medical University), Fujian Province University, Fuzhou, China.
- Medical Genetic Diagnosis and Therapy Center of Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Provincial Key Laboratory of Prenatal Diagnosi…
ORCID-Profile: Junhao Zheng, Liangpu Xu, Hailong Huang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
- National Key Clinical Specialty Discipline Construction Program of China
Zitieren
APA
Zheng, J., Chen, M., Zhang, S., Lv, A., Zhang, M., Chen, L., Lin, N., Xu, L., & Huang, H. (2025). Fujian Province β‐Thalassemia: A Molecular and Hematological Study in Southeastern China. Genetics Research, 2025(1). https://doi.org/10.1155/genr/8862095
Vancouver
Zheng J, Chen M, Zhang S, Lv A, Zhang M, Chen L, et al. Fujian Province β‐Thalassemia: A Molecular and Hematological Study in Southeastern China. Genetics Research. 2025;2025(1). doi:10.1155/genr/8862095
BibTeX
@article{Zheng2025,
author = {Zheng, Junhao and Chen, Meihuan and Zhang, Siwen and Lv, Aixiang and Zhang, Min and Chen, Lingji and Lin, Na and Xu, Liangpu and Huang, Hailong},
title = {Fujian Province β‐Thalassemia: A Molecular and Hematological Study in Southeastern China},
journal = {Genetics Research},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/genr/8862095}
}
EUVIMED